Evidence map›Paper›PMID 30842317›Full record

ArticleJournal of virology2019

Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK.

Keren Nebenzahl-Sharon, Hassan Shalata, Rakefet Sharf, Jana Amer, Hanan Khoury-Haddad, Sook-Young Sohn, Nabieh Ayoub, Patrick Hearing, Tamar Kleinberger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Keren Nebenzahl-Sharon *Department of Microbiology, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Hassan Shalata *Department of Microbiology, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Rakefet SharfDepartment of Microbiology, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Jana AmerDepartment of Microbiology, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Hanan Khoury-HaddadFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Sook-Young SohnDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Nabieh AyoubFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Patrick HearingDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Tamar KleinbergerDepartment of Microbiology, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel tamark@technion.ac.il.ORCID 0000-0002-0300-8679
Technion – Israel Institute of Technology · ILStony Brook University · US

Funding

Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 ProteinR01CA122677 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HEARING, PATRICK · 2007 to 2022
$5.2M
NCI NIH HHS R01 CA122677
6 · The paper itself

Abstract

The adenovirus (Ad) E4orf4 protein contributes to virus-induced inhibition of the DNA damage response (DDR) by reducing ATM and ATR signaling. Consequently, E4orf4 inhibits DNA repair and sensitizes transformed cells to killing by DNA-damaging drugs. Inhibition of ATM and ATR signaling contributes to the efficiency of virus replication and may provide one explanation for the cancer selectivity of cell death induced by the expression of E4orf4 alone. In this report, we investigate a direct interaction of E4orf4 with the DDR. We show that E4orf4 physically associates with the DNA-dependent protein kinase (DNA-PK), and we demonstrate a biphasic functional interaction between these proteins, wherein DNA-PK is required for ATM and ATR inhibition by E4orf4 earlier during infection but is inhibited by E4orf4 as infection progresses. This biphasic process is accompanied by initial augmentation and a later inhibition of DNA-PK autophosphorylation as well as by colocalization of DNA-PK with early Ad replication centers and distancing of DNA-PK from late replication centers. Moreover, inhibition of DNA-PK improves Ad replication more effectively when a DNA-PK inhibitor is added later rather than earlier during infection. When expressed alone, E4orf4 is recruited to DNA damage sites in a DNA-PK-dependent manner. DNA-PK inhibition reduces the ability of E4orf4 to induce cancer cell death, likely because E4orf4 is prevented from arriving at the damage sites and from inhibiting the DDR. Our results support an important role for the E4orf4-DNA-PK interaction in Ad replication and in facilitation of E4orf4-induced cancer-selective cell death.

Indexed as

AdenoviridaeAdenoviridae InfectionsAdenovirus E4 ProteinsAdenoviruses, HumanAtaxia Telangiectasia Mutated ProteinsCell LineDNA-Activated Protein KinaseDNA-Binding ProteinsDNA DamageDNA RepairDNA, ViralHeLa CellsHumansNuclear ProteinsPhosphorylationSignal TransductionAdenovirus E4 ProteinsAtaxia Telangiectasia Mutated ProteinsATR protein, humanDNA-Activated Protein KinaseDNA-Binding ProteinsDNA, ViralE4orf4 protein, adenovirusNuclear ProteinsViral ProteinsadenovirusesDNA damage responseDNA-PKE4orf4

Identifiers

PMID30842317
PMCPMC6498064
OpenAlexW2918713007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.